Assessment of Different Modified POEM for Achalasia
Primary Purpose
Esophageal Achalasia
Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
conventional myotomy
short myotomy
full-thickness myotomy
tailored myotomy
Sponsored by
About this trial
This is an interventional treatment trial for Esophageal Achalasia focused on measuring peroral endoscopic myotomy, Achalasia
Eligibility Criteria
Inclusion Criteria:
- Subjects diagnosed as achalasia type I, II, or III on the basis of the results of established methods (barium swallow, manometry, esophagogastroduodenoscopy)
- Candidate for a POEM
- No contra-indication to general anesthesia
- Their age is ≥14years and ≤70 years
- Able to give written consent
Exclusion Criteria:
- Previous myotomy for achalasia: any of previous Heller myotomy, endoscopic myotomy
- Previous mediastinal surgery
- Any anatomical esophageal anomaly that in the opinion of the investigator may render the intervention more difficult, such as sigmoid esophagus on the pre-operative barium swallow, esophageal diverticula or hiatal hernia.
- Any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure
- Pregnant or lactating female
- Subjects with coagulopathy
Sites / Locations
- Department of Gastroenterology, Peking Union Medical College HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Active Comparator
Experimental
Experimental
Experimental
Arm Label
conventional myotomy
short myotomy
full-thickness myotomy
tailored myotomy
Arm Description
conventional myotomy for achalasia type I, II and III
modified myotomy (short myotomy) for achalasia type I and II
modified myotomy (full-thickness myotomy) for achalasia type I and II
modified myotomy (tailored myotomy) for achalasia type III
Outcomes
Primary Outcome Measures
Therapeutic success of short term
Therapeutic success is defined as a reduction in the Eckardt score to ≤3. The Eckardt score is the sum of the symptom scores for dysphagia, regurgitation, and chest pain (with a score of 0 indicating the absence of symptoms, 1 indicating occasional symptoms, 2 indicating daily symptoms, and 3 indicating symptoms at each meal) and weight loss (with 0 indicating no weight loss, 1 indicating a loss of <5 kg, 2 indicating a loss of 5 to 10 kg, and 3 indicating a loss of >10 kg) (Eckardt, V. Gastroenterology, 1992. 103(6): 1732-8.
Therapeutic success of long term
Therapeutic success is defined as a reduction in the Eckardt score to ≤3.
Rate of intra-procedure complications
Complications encountered during the procedure will be noted. (perforation, delayed bleeding, pneumothorax, subcutaneous emphysema, anastomotic leak etc.)
Rate of GERD
Gastro-esophageal reflux disease (GERD) is identified by positive results of esophageal pH-impedance/pH-monitoring (DeMeester score), gastro-esophageal reflux symptom assessment (GerdQ questionnaire) or esophagogastroduodenoscopy (reflux esophagitis).
Secondary Outcome Measures
Procedure time
The duration of the endoscopic procedures for each patients will be calculated, in minutes, since the mucosal incision until the endoscopic closure of the mucosal entry with the last endoscopic clip.
Pressure changes by high-resolution manometry (HRM)
Basal lower esophageal sphincter (LES) pressure and integrated relaxation pressure (IRP)
Change in barium column height by barium esophagogram
Barium swallow studies will be done to evaluate the oesophageal emptying at 5 minutes
Full Information
NCT ID
NCT04578769
First Posted
September 26, 2020
Last Updated
March 28, 2023
Sponsor
Peking Union Medical College Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04578769
Brief Title
Assessment of Different Modified POEM for Achalasia
Official Title
Comparison Study of Conventional Peroral Endoscopic Myotomy (POEM) and Different Modified Procedures of POEM for Achalasia
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 2, 2020 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Peking Union Medical College Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aims of this study are 1) to compare the efficacy and safety of conventional myotomy (long myotomy) and modified myotomy (short myotomy) in the treatment of type I/II achalasia patients diagnosed according to Chicago Classification; 2) to compare the efficacy and safety of conventional myotomy (circular myotomy) and modified myotomy (full-thickness myotomy) in the treatment of type I/II achalasia patients; 3) to compare the efficacy and safety of conventional myotomy (non-tailored myotomy) and modified myotomy (tailored myotomy) in the treatment of type III achalasia patients.
Detailed Description
Peroral endoscopic myotomy (POEM) is a novel clinical technique used to treat achalasia. The conventional POEM myotomy length averages 8 to 10 cm (4-6 cm in the esophagus, 2-4cm in the LES, 2cm in the cardia & 6-8 cm above and 2 cm below the gastroesophageal junction [GEJ]) for typical achalasia (Chicago classification I, II), but there is no guideline or expert consensus with regard to minimal myotomy length recommended in POEM.
Based on the facts that achalasia is a primary motor disorder of LES dysfunction, patients with type I/II achalasia may achieve a satisfactory outcome with shorter myotomy in procedure of modified POEM, which only focused on the forced relaxation of the LES. Recently, some retrospective studies have suggested that shorter myotomy is comparable with longer myotomy for treating achalasia with regard to clinical efficacy and has the advantage of shorter procedure time, which needs to be further confirmed by more prospective studies.
In terms with the International Peroral Endoscopic Myotomy Survey, a longer myotomy is recommended for patients with type III achalasia. The length of myotomy in type III achalasia can be gauged by high-resolution manometry (HRM). Recent research showed that postoperative Eckardt score was significantly improved in the tailored group (myotomy length informed by HRM) versus non-tailored for type III achalasia, but this study was limited by its retrospective nature.
There is still no conclusion on the thickness of muscle bundle dissection recommended during POEM. Selective circular muscle myotomy is designed to avoid gastroesophageal reflux (GER) postoperatively and decrease morbidity during POEM. But one meta-analysis showed that Heller's surgery could keep patients in long-time remission, mainly because of its full-thickness muscle bundle dissection to make sure of persist relaxation of LES. A retrospective study comparing the outcomes of full-thickness and circular muscle myotomy showed no differences in efficacy, GER or adverse events, although the procedural time was shorter in the full thickness myotomy group.
Further randomized controlled trials are warranted to assess the efficacy and safety of different modified myotomy approaches in POEM for patients with achalasia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Achalasia
Keywords
peroral endoscopic myotomy, Achalasia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
325 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
conventional myotomy
Arm Type
Active Comparator
Arm Description
conventional myotomy for achalasia type I, II and III
Arm Title
short myotomy
Arm Type
Experimental
Arm Description
modified myotomy (short myotomy) for achalasia type I and II
Arm Title
full-thickness myotomy
Arm Type
Experimental
Arm Description
modified myotomy (full-thickness myotomy) for achalasia type I and II
Arm Title
tailored myotomy
Arm Type
Experimental
Arm Description
modified myotomy (tailored myotomy) for achalasia type III
Intervention Type
Procedure
Intervention Name(s)
conventional myotomy
Other Intervention Name(s)
long myotomy, circular myotomy, non-tailored myotomy
Intervention Description
Initial mucosal incision. After submucosal injection, a reverse T entry incision is made at approximately 10 cm proximal to the gastroesophageal junction (GEJ).
Submucosal tunnel establishment. A submucosal tunnel is created to 2-3 cm distal to the GEJ.
Endoscopic myotomy. A selective circular muscle myotomy is carried out in a proximal to distal direction, from 2 cm distal to the mucosal entry down to 2 cm distal to the GEJ.
Zippered closure of mucosal entry. The mucosal incision is closed using hemostatic clips.
Intervention Type
Procedure
Intervention Name(s)
short myotomy
Other Intervention Name(s)
modified myotomy
Intervention Description
Initial mucosal incision. After submucosal injection, a reverse T entry incision is made at approximately 6 cm proximal to the gastroesophageal junction (GEJ).
Submucosal tunnel establishment. A submucosal tunnel is created to 2-3 cm distal to the GEJ.
Endoscopic myotomy. A selective circular muscle myotomy is carried out in a proximal to distal direction, from 2 cm distal to the mucosal entry down to 2 cm distal to the GEJ.
Zippered closure of mucosal entry. The mucosal incision is closed using hemostatic clips.
Intervention Type
Procedure
Intervention Name(s)
full-thickness myotomy
Other Intervention Name(s)
modified myotomy
Intervention Description
Initial mucosal incision. After submucosal injection, a reverse T entry incision is made at approximately 10 cm proximal to the gastroesophageal junction (GEJ).
Submucosal tunnel establishment. A submucosal tunnel is created to 2-3 cm distal to the GEJ.
Endoscopic myotomy. A selective circular muscle myotomy is carried out in a proximal to distal direction, from 2 cm distal to the mucosal entry down to 4 cm proximal to the GEJ, and a full-thickness muscle myotomy is continually carried out from 4cm proximal to the GEJ down to 2 cm distal to the GEJ.
Zippered closure of mucosal entry. The mucosal incision is closed using hemostatic clips.
Intervention Type
Procedure
Intervention Name(s)
tailored myotomy
Other Intervention Name(s)
modified myotomy
Intervention Description
Initial mucosal incision. After submucosal injection, a reverse T entry incision is made at approximately 2 cm proximal to the spastic segment within the esophageal body, which is identified based on information gained from high-resolution manometry (HRM).
Submucosal tunnel establishment. A submucosal tunnel is created to 2-3 cm distal to the GEJ.
Endoscopic myotomy. A selective circular muscle myotomy is carried out in a proximal to distal direction, from 2 cm distal to the mucosal entry down to 2 cm distal to the GEJ.
Zippered closure of mucosal entry. The mucosal incision is closed using hemostatic clips.
Primary Outcome Measure Information:
Title
Therapeutic success of short term
Description
Therapeutic success is defined as a reduction in the Eckardt score to ≤3. The Eckardt score is the sum of the symptom scores for dysphagia, regurgitation, and chest pain (with a score of 0 indicating the absence of symptoms, 1 indicating occasional symptoms, 2 indicating daily symptoms, and 3 indicating symptoms at each meal) and weight loss (with 0 indicating no weight loss, 1 indicating a loss of <5 kg, 2 indicating a loss of 5 to 10 kg, and 3 indicating a loss of >10 kg) (Eckardt, V. Gastroenterology, 1992. 103(6): 1732-8.
Time Frame
6 months after the procedure
Title
Therapeutic success of long term
Description
Therapeutic success is defined as a reduction in the Eckardt score to ≤3.
Time Frame
2 years after the procedure
Title
Rate of intra-procedure complications
Description
Complications encountered during the procedure will be noted. (perforation, delayed bleeding, pneumothorax, subcutaneous emphysema, anastomotic leak etc.)
Time Frame
During the endoscopic procedure
Title
Rate of GERD
Description
Gastro-esophageal reflux disease (GERD) is identified by positive results of esophageal pH-impedance/pH-monitoring (DeMeester score), gastro-esophageal reflux symptom assessment (GerdQ questionnaire) or esophagogastroduodenoscopy (reflux esophagitis).
Time Frame
2 years after the procedure
Secondary Outcome Measure Information:
Title
Procedure time
Description
The duration of the endoscopic procedures for each patients will be calculated, in minutes, since the mucosal incision until the endoscopic closure of the mucosal entry with the last endoscopic clip.
Time Frame
During the endoscopic procedure
Title
Pressure changes by high-resolution manometry (HRM)
Description
Basal lower esophageal sphincter (LES) pressure and integrated relaxation pressure (IRP)
Time Frame
2 years after the procedure
Title
Change in barium column height by barium esophagogram
Description
Barium swallow studies will be done to evaluate the oesophageal emptying at 5 minutes
Time Frame
2 years after the procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects diagnosed as achalasia type I, II, or III on the basis of the results of established methods (barium swallow, manometry, esophagogastroduodenoscopy)
Candidate for a POEM
No contra-indication to general anesthesia
Their age is ≥14years and ≤70 years
Able to give written consent
Exclusion Criteria:
Previous myotomy for achalasia: any of previous Heller myotomy, endoscopic myotomy
Previous mediastinal surgery
Any anatomical esophageal anomaly that in the opinion of the investigator may render the intervention more difficult, such as sigmoid esophagus on the pre-operative barium swallow, esophageal diverticula or hiatal hernia.
Any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure
Pregnant or lactating female
Subjects with coagulopathy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tao Guo, MD
Phone
8610-69155017
Email
guoqiong990@126.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tao Guo, MD
Organizational Affiliation
Peking Union Medical College Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Gastroenterology, Peking Union Medical College Hospital
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100730
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tao Guo, MD
Phone
8610-69155017
Email
guoqiong990@126.com
First Name & Middle Initial & Last Name & Degree
Tao Guo, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
25469569
Citation
Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE; International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015 Feb;27(2):160-74. doi: 10.1111/nmo.12477. Epub 2014 Dec 3.
Results Reference
background
PubMed Identifier
31559513
Citation
Inoue H, Shiwaku H, Kobayashi Y, Chiu PWY, Hawes RH, Neuhaus H, Costamagna G, Stavropoulos SN, Fukami N, Seewald S, Onimaru M, Minami H, Tanaka S, Shimamura Y, Santi EG, Grimes K, Tajiri H. Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from an international multicenter experience. Esophagus. 2020 Jan;17(1):3-10. doi: 10.1007/s10388-019-00689-6. Epub 2019 Sep 26.
Results Reference
background
PubMed Identifier
30022514
Citation
Inoue H, Shiwaku H, Iwakiri K, Onimaru M, Kobayashi Y, Minami H, Sato H, Kitano S, Iwakiri R, Omura N, Murakami K, Fukami N, Fujimoto K, Tajiri H. Clinical practice guidelines for peroral endoscopic myotomy. Dig Endosc. 2018 Sep;30(5):563-579. doi: 10.1111/den.13239.
Results Reference
background
PubMed Identifier
25214469
Citation
Wang J, Tan N, Xiao Y, Chen J, Chen B, Ma Z, Zhang D, Chen M, Cui Y. Safety and efficacy of the modified peroral endoscopic myotomy with shorter myotomy for achalasia patients: a prospective study. Dis Esophagus. 2015 Nov-Dec;28(8):720-7. doi: 10.1111/dote.12280. Epub 2014 Sep 12.
Results Reference
background
PubMed Identifier
30187204
Citation
Li L, Chai N, Linghu E, Li Z, Du C, Zhang W, Zou J, Xiong Y, Zhang X, Tang P. Safety and efficacy of using a short tunnel versus a standard tunnel for peroral endoscopic myotomy for Ling type IIc and III achalasia: a retrospective study. Surg Endosc. 2019 May;33(5):1394-1402. doi: 10.1007/s00464-018-6414-7. Epub 2018 Sep 5.
Results Reference
background
PubMed Identifier
30054739
Citation
Kane ED, Budhraja V, Desilets DJ, Romanelli JR. Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia. Surg Endosc. 2019 Mar;33(3):886-894. doi: 10.1007/s00464-018-6356-0. Epub 2018 Jul 27.
Results Reference
background
PubMed Identifier
27895430
Citation
Wang XH, Tan YY, Zhu HY, Li CJ, Liu DL. Full-thickness myotomy is associated with higher rate of postoperative gastroesophageal reflux disease. World J Gastroenterol. 2016 Nov 14;22(42):9419-9426. doi: 10.3748/wjg.v22.i42.9419.
Results Reference
background
PubMed Identifier
23891074
Citation
Li QL, Chen WF, Zhou PH, Yao LQ, Xu MD, Hu JW, Cai MY, Zhang YQ, Qin WZ, Ren Z. Peroral endoscopic myotomy for the treatment of achalasia: a clinical comparative study of endoscopic full-thickness and circular muscle myotomy. J Am Coll Surg. 2013 Sep;217(3):442-51. doi: 10.1016/j.jamcollsurg.2013.04.033. Epub 2013 Jul 25.
Results Reference
background
Learn more about this trial
Assessment of Different Modified POEM for Achalasia
We'll reach out to this number within 24 hrs